Currently funded projects
The Kids' Cancer Project has committed over $75 million to research projects across Australia.
- Leukaemia
- Discover
Dr Klaartje Somers
Project title: Targeting NAD metabolism to overcome therapeutic resistance in adult and paediatric acute myeloid leukaemia Institute: Children’s Cancer Institute Funding: $181,559 (30 June 2023 – 30 June 2026) Funding partners: Cancer Australia (PdCCRS) Research Pillar: Discover Cancer Type:
Haematological cancers (Acute myeloid leukaemia)
- Sarcoma
- Discover
Dr Jacqui McGovern
Project title: From bench to bedside – Developing an osteosarcoma precision oncology workflow Institute: Queensland University of Technology Funding: $199,171 (January 2022 – July 2026) Funding partners: The Tie Dye Project Research Pillar: Discover Cancer Type:
Sarcoma (Osteosarcoma)
- Sarcoma
- Translate
Dr Elizabeth Connolly
Project title: Addressing unmet clinical needs in paediatric and AYA sarcoma through a program of clinical and translational research Type of fellowship: ANZSA Clinical Research Fellowship Institute: Children's Medical Research Institute; Peter MacCallum Cancer Centre Funding: $170,000 (March 2025 – February 2027) Research Pillar: Translate Cancer Type:
Sarcoma (Osteosarcoma, Ewing Sarcoma)
- Sarcoma
- Translate
Associate Professor Geoff McCowage
Project title: INTER-EWING-1: INTERnational scientific program in clinical research to improve outcomes of newly diagnosed EWING sarcoma - trial 1 Institute: ANZCHOG Funding: $150,000 (July 2022 – December 2027) Funding partners: Cooper Rice-Brading Foundation Research Pillar: Translate Cancer Type:
Sarcoma (Ewing sarcoma)
- Brain cancer
- Translate
Professor Nick Gottardo
Project title: CONNECT-1903: A Pilot and Surgical Study of Larotrectinib for Treatment of Children with Newly-Diagnosed High-Grade Glioma with NTRK Fusion. Institute: ANZCHOG Funding: $54,095 (July 2020 – December 2027) Funding partners: Medical Research Future Fund (MRFF) Love for Lachie Research Pillar: Translate Cancer Type:
Brain and CNS (High-grade glioma with NTRK fusion)
- Various cancer types
Comprehensive analysis of gene changes in childhood cancer patients and their parents
Recipient: Dr Bhavna Padhye
Institute: Children's Cancer Research Unit, The Children's Hospital at Westmead.
The Kids' Cancer Project Funding: $91,000 August 2023 to August 2024
Perpetual Funding: $91,100
- Various cancer types
Col Reynolds Fellowships, Megumi Hui Ai Lim
Recipient: Megumi (Meg) Lim
Institute: Queensland University of Technology
Funding: $20,000.00
PhD Scholarship - Top Up
- Sarcoma
Towards safe and effective immunotherapy for soft tissue sarcomas
Recipient: Dr Ben Wylie
Institute: Telethon Kids' Institute
Funding: $89,300 January 2023 to June 2024 (The Kids' Cancer Project: $39,300, Colliers Charitable Fund: $50,000)
- Sarcoma
Training Natural Killer cells for Immunotherapy for children, adolescent, and adults with sarcoma
Recipients: Assoc. Prof. Fernando Guimaraes & Assoc. Prof. Wayne Nicholls
Institute: The Fraser Institute – UoQ
TKCP Funding: $100,000 March 2024 to September 2025
The Tie Dye Project: $100,000
Cooper Rice Brading Foundation: $50,000
Total Funding: $250,000
- Brain cancer
Col Reynolds Fellow, Philipp Graber
Recipient: Philipp Graber
Institute: Children’s Cancer Institute
Funding: $25,000.00
PhD Scholarship - Top Up
- Brain cancer
A new and effective combination therapy for children with brain cancer
Recipient: Professor Brandon Wainwright
Institute: University of Queensland
The Kids' Cancer Project Funding: $91,392 July 2022 – June 2024
Dalwood Wylie Foundation: $30,000
Perpetual Funding: $120,000
Total Funding: $241,392
- Various cancer types
Identification of Megakaryocyte and Platelet Bone Marrow Niches
Recipient: Dr Gavin Tjin
Institute: St Vincent's Institute of Medical Research
Funding: $199,970.50 February 2022 to February 2024 (Cancer Australia PdCCRS funding $50,314.50 and The Kids' Cancer Project funding $149,656)
- Sarcoma
- Translate
Clinical translation of CAR T cell therapy for the treatment of sarcoma
Recipient: A/Professor Geoff McCowage & Dr Kavitha Gowrishankar
Institute: Children's Hospital at Westmead
Funding: $281,000 October 2021 to September 2024 (The Kids' Cancer Project: $115,500, The Tie Die Project: $115,500, The Children's Cancer Research Unit: $50,000)
- Various cancer types
RECOVER – Responding to late effects in survivors of childhood cancer
Recipient: Dr Natalie Bradford
Institute: Queensland University of Technology (QUT)
Funding: $299,882 July 2022 to June 2025
- Various cancer types
- Translate
Preclinical drug-testing to evaluate PARP inhibitors for infants with acute lymphoblastic leukaemia
Recipient: Dr Rishi Kotecha
Institute: Telethon Kids' Institute
Funding: $143,908 July 2021 to December 2022
Perpetual Funding: $120,000
- Various cancer types
(GENIE) A combined GENetic and follicle density risk prediction approach to identifying InfErtility risk in paediatric cancer patients
Recipient: Dr Rachel Conyers
Institute: The Murdoch Children’s Research Institute
Funding: $301,752 July 2022 to June 2025
- Various cancer types
Pharmacogenetics real-time implementation of rare-toxicity predisposition (PRIORITY-P)
Recipient: Dr Rachel Conyers
Institute: The Murdoch Children’s Research Institute
Funding: $286,502 July 2022 to June 2025
- Various cancer types
iBounce digital health educational program
Recipient: Dr Lauren Ha
Institute: School of Health Sciences, UNSW Medicine, UNSW Sydney Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children’s Hospital Randwick
Funding: $599,935 January 2022 to June 2025
- DIPG
Targeting the thioredoxin system as a novel strategy for DIPG
Recipient: Associate Professor David Ziegler and Dr Dannielle Upton
Institute: Children’s Cancer Institute
Funding: $329,440 January 2022 to December 2024
- Sarcoma
Identification of a sarcoma molecular prognostic and therapy resistance signature
Recipient: Dr Jason Cain
Institute: Hudson Institute of Medical Research
The Kids' Cancer Project Funding: $50,542 January 2022 – June 2023
Perpetual Funding: $89,930
Total Funding: $140,472
- Brain cancer
- Discover
Pharmaco-phospho-proteo-genomics of paediatric high-grade glioma (HGG)
Recipient: Associate Professor Matt Dun
Institute: The University of Newcastle, Hunter Medical Research Institute
Funding: $300,000 October 2021 to September 2024
- Various cancer types
Reducing long-term side-effects of chemotherapy in cancer survivors
Recipient: Professor Irina Vetter
Institute: The University of Queensland
Funding: $298,141 October 2021 to September 2024
- Sarcoma
- Discover
Exploiting the DNA damage response in paediatric sarcoma
Recipient: Dr Emmy Fleuren and Dr Emmy Dolman
Institute: Children’s Cancer Institute
Funding: $261,649 June 2021 to June 2024
- Sarcoma
Detecting chemotherapy resistance and sequencing residual malignant tissues in sarcoma treatment
Recipient: Professor Glenn Marshall
Institute: Children's Cancer Institute
Funding: $220,000 January 2022 to December 2023
- Leukaemia
Targeting altered serine metabolism in MLL-rearranged paediatric acute myeloid leukaemia (AML)
Recipient: Professor Ricky Johnstone
Institute: Peter MacCallum Cancer Centre
Funding: $218,338 October 2021 to September 2023
- Brain cancer
- Translate
Enhancing radiation therapy to improve survival outcomes for children with aggressive brain cancer
Recipient: Professor Nick Gottardo
Institute: Telethon Kids Institute
Funding: $108,556 October 2021 to September 2022
- Sarcoma
- Discover
Identifying the right sarcoma treatment at the right time
Recipient: Dr Emmy Fleuren
Institute: Children's Cancer Institute
Funding: $373,599 June 2021 to June 2024 (The Kids' Cancer Project: $186,799.50, The Cooper Rice-Brading Foundation: $186,799.50)
- Various cancer types
National Tumour Biobanking Network
Recipient: Associate Professor Andrew Moore
Institute: University of Queensland
Funding: $642,168 July 2015 to June 2024
- Sarcoma
Targeting IL-23 in bone and soft tissue sarcomas
Recipient: Professor David Thomas
Institute: Garvan Institute of Medical Research
Funding: $100,000 March 2021 to March 2023
- Neuroblastoma
Enhanced polyamine depletion for aggressive childhood cancers
Recipient: Professor Michelle Haber
Institute: Children’s Cancer Institute
TKCP funding: $239,995 January 2021 to December 2023
PdCCRS* funding: $347,705
Total funding: $587,700
- Medulloblastoma
Personalised targeted therapy for adolescent and young adult medulloblastoma patients
Recipient: Dr Elizabeth Hovey
Institute: Nelune Comprehensive Cancer Centre
TKCP funding: $287,322 July 2020 to June 2023
PdCCRS* funding: $287,322
Total funding: $574,664
- Medulloblastoma
Application of gene-silencing nanodrugs to inhibit medulloblastoma growth
Recipient: Associate Professor Joshua McCarroll
Institute: Children’s Cancer Institute
TKCP funding: $298,554 December 2019 to January 2023
PdCCRS* funding: $298,554
Total funding: $597,108
Displaying results
33
-
64
of
118
Pages